/PRNewswire/ CTI BioPharma Corp. (Nasdaq: CTIC) today announced five poster presentations from the Company s pacritinib program at the 63rd American Society.
Clinical Challenges: Timely Testing for Genetic Mutations in AML medpagetoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medpagetoday.com Daily Mail and Mail on Sunday newspapers.